|
HMMR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.34000000054868E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.155100E-04 |
| Normal-vs-Stage2 |
8.541800E-03 |
| Normal-vs-Stage3 |
8.40619999999959E-05 |
| Normal-vs-Stage4 |
1.46649999999138E-06 |
| Stage1-vs-Stage2 |
2.665000E-01 |
| Stage1-vs-Stage3 |
3.972100E-02 |
| Stage1-vs-Stage4 |
3.247700E-04 |
| Stage2-vs-Stage3 |
8.377200E-01 |
| Stage2-vs-Stage4 |
2.998100E-02 |
| Stage3-vs-Stage4 |
2.010100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.71630000048262E-07 |
| Normal-vs-AfricanAmerican |
1.086020E-01 |
| Normal-vs-Asian |
1.724390E-01 |
| Caucasian-vs-AfricanAmerican |
3.753100E-04 |
| Caucasian-vs-Asian |
4.984000E-01 |
| AfricanAmerican-vs-Asian |
2.578800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.40589999975127E-07 |
| Normal-vs-Female |
9.208400E-04 |
| Male-vs-Female |
8.316500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.505600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.0087000000002E-05 |
| Normal-vs-Age(61-80Yrs) |
1.58609999999504E-05 |
| Normal-vs-Age(81-100Yrs) |
5.829800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.849600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.250000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.535980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.507800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.683800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.953790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.967000E-01 |
| Normal-vs-Grade 2 |
3.559900E-04 |
| Normal-vs-Grade 3 |
3.36160000002916E-06 |
| Normal-vs-Grade 4 |
1.85692999999931E-05 |
| Grade 1-vs-Grade 2 |
7.174600E-04 |
| Grade 1-vs-Grade 3 |
2.19919999999707E-06 |
| Grade 1-vs-Grade 4 |
3.50719999999693E-05 |
| Grade 2-vs-Grade 3 |
4.526100E-02 |
| Grade 2-vs-Grade 4 |
7.572400E-04 |
| Grade 3-vs-Grade 4 |
3.557200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.815300E-03 |
| Normal-vs-ccB subtype |
8.21169999998261E-07 |
| ccA subtype-vs-ccB subtype |
4.750400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.59369999999104E-05 |
| Normal-vs-N1 |
5.935900E-03 |
| N0-vs-N1 |
2.994400E-02 |
|
|
